Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Schering researchers prepare and test novel MCH antagonists

July 7, 2003

rhIGF-I/rhIGFBP-3 enters phase III trial for GHIS

July 7, 2003

FDA delays Estrasorb decision date

July 4, 2003

Low-dose Prempro launched

July 3, 2003

Indications for Forcaltonin expanded in Europe

July 3, 2003

Novel potentiators of glucose transport designed by Ajinomoto researchers

July 3, 2003

New inhibitors of ileal bile acid transport under study at Sankyo

July 3, 2003

CPMP hands down positive opinion for Avandamet

July 2, 2003

Novel glucagon antagonists in Novo Nordisk development pipeline

July 2, 2003

Roche researchers describe the preparation and use of novel cathepsin K inhibitors

July 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...